About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Bayer Implements SunGard Adaptiv Solutions to Support Risk Management

Subscribe to our newsletter

Germany’s Bayer AG has implemented a selection of SunGard’s Adaptiv solutions for risk management to ensure it meets the fair value accounting mandates of the International Financial Reporting Standards (IFRS 13) and is ready to comply with European Market Infrastructure Regulation that is expected to come into force later this year.

The German enterprise that specialises in healthcare, agriculture and high-tech materials on a global basis, went live with the SunGard solutions late last year and has completed first quarter reporting with the risk calculation systems.

The company is using SunGard Adaptiv 360 for trade capture, position keeping and to calculate sensitivities. It is also using Adaptiv Analytics to support Monte Carlo based calculations of risk measures such as value at risk, potential future exposure, credit valuation adjustment (CVA) and debt valuation adjustment (DVA). Adaptiv Risk Cube provides Bayer’s risk managers with the means to drill down and analyse risk results, while Adaptiv Operations integrates risk results with back-office functionality and the company’s treasury platform.

The SunGard solutions provide an automated approach to risk calculation and management, replacing a pragmatic method that included manual short cuts and inherent operational risk.

According to Alexander Burck, head of corporate financial control at Bayer, “To help mitigate risks, Bayer decided to use the same risk management methodologies used by some of the largest and most advanced global banks. SunGard’s Adaptiv solutions enable Bayer to determine, monitor and steer its counterparty risk accurately and consistently across its counterparties. With the automated Adaptiv Analytics solution in particular, we are able to calculate Monte Carlo based CVA and DVA and attribute the results accurately to the trade level, even within netting sets, helping us to comply with regulations such as IFRS 13.”

For SunGard, Bayer is a good win in the corporate market. Sven Ludwig, director for risk, SunGard Adaptiv, says: “We see most demand for Adaptiv solutions in capital markets, but more demand is coming from corporate markets where companies are focussing on risk to meet increasing regulation.” Reflecting the corporate sector’s slight lag behind the banking sector in terms of automated risk management, Bayer is reporting on an end-of-day basis on many of its risk measures, but is expected to work with SunGard to meet the emerging banking standard of real-time reporting.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Unlocking value: Harnessing modern data platforms for data integration, advanced investment analytics, visualisation and reporting

Modern data platforms are bringing efficiencies, scalability and powerful new capabilities to institutions and their data pipelines. They are enabling the use of new automation and analytical technologies that are also helping firms to derive more value from their data and reduce costs. Use cases of specific importance to the finance sector, such as data...

BLOG

Bloomberg BQuant Wins A-Team AICM Best AI Solution for Historical Data Analysis Award

When global markets were roiled by the announcement of massive US trade tariffs, Bloomberg saw the amount of financial and other data that runs through its systems surge to 600 billion data points, almost double the 400 billion it manages on an average day. “These were just mind-blowingly large volumes of data,” says James Jarvis,...

EVENT

Buy AND Build: The Future of Capital Markets Technology

Buy AND Build: The Future of Capital Markets Technology London examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

Evaluated Pricing

Valuations and pricing teams are facing a much higher degree of scrutiny from both the regulatory community and the investor community in the glare of the post-crisis data transparency spotlight. Fair value price transparency requirements and the gradual move towards a more harmonised accounting standards environment is set within the context of the whole debate...